This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2022 Remove Chronic pain management Remove Mental health Related Topics
Pain management Remote care Health Policy healthcare technology Health Technology Connected Health Telehealth Public Health Leadership Telemedicine More Related Topics >
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

NOVEMBER 25, 2023

These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. The most active subsectors for DTx M&A deals are mental health, oncology, and diabetes. EV to EBITDA: 12.5x The average deal size for DTx M&A deals is increasing.

Pharmaceuticals 67
Pharmaceuticals Pain management Chronic pain management Mental health 67
article thumbnail

2023 Preview of Telemental Health Laws & Behavioral Telehealth Regulations

Telebehavioral Health Institute

DECEMBER 22, 2022

After continuing COVID-related telemental health laws and behavioral telehealth regulations in 2022, many key issues for 2023 are already decided. First, the Public Health Emergency (PHE) is likely to be extended for three months in January, bringing today’s best predictions for the end of the PHE to April 2023.

Telehealth 75
Telehealth Medicare Mental health Telemedicine 75
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024